Celgene resubmits MS drug, ozanimod, to FDA
admin 27th March 2019 Uncategorised 0A filing for ozanimod was initially rejected by the US regulator in February 2017.
More: Celgene resubmits MS drug, ozanimod, to FDA
Source: News
A filing for ozanimod was initially rejected by the US regulator in February 2017.
More: Celgene resubmits MS drug, ozanimod, to FDA
Source: News
© 1994 - 2026 B.M. Pharmaceuticals